Company: SRPT
Filing Date: 2025-07-21
Form Type: 8-K
Source: 0001193125-25-161516
Chunk: 0

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-07-21
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01.      Other Events.  

On July 21, 2025, the Company announced that the U. S. Food and Drug Administration (“ FDA”) has placed a clinical hold on the Company’s investigational gene therapy clinical trials for limb girdle muscular dystrophy (“ LGMD”). The hold includes the Company’s LGMD clinical trials related to its product candidates SRP-9003(LGMD2E/R4/bidridistrogene xeboparvovec), SRP-9004(LGMD2D/patidistrogene bexoparvovec), SRP-6004(LGMD2B/R2), andSRP-9005(LGMD2C/R5 g-sarcoglycan).